Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
CSX Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $90.8B | |
|---|---|---|
| P/E (forward) | 21.9x |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $12.52B | $14.85B | $14.66B | $14.54B | $14.09B | +3.0% |
| Gross profit | $5.29B | $5.72B | $5.60B | $5.51B | $4.69B | -3.0% |
| Operating income | $5.59B | $5.95B | $5.50B | $5.25B | $4.52B | -5.2% |
| Net income | $3.78B | $4.11B | $3.67B | $3.47B | $2.89B | -6.5% |
| EPS (diluted) | $1.68 | $1.92 | $1.82 | $1.79 | $1.54 | -2.2% |
| EBITDA | $7.09B | $7.59B | $7.27B | $7.07B | $5.87B | -4.6% |
| R&D | — | — | — | — | — | — |
| SG&A | $64.0M | $79.0M | $29.0M | $50.0M | $33.0M | -15.3% |
Recent company headlines from major financial publishers.
Positive rail growth supports a measured recovery. This path fails if rail growth stalls, operating margin misses the Base endpoint, or investment intensity remains elevated through FY2028.
The higher outcome needs stronger operations and cash than Base. Persistent rail growth and a higher margin raise profit; lower investment spending must then turn more of that profit into free cash flow.
| Ke ↓ / g → | 0.5% | 0.5% | 1.0% | 1.5% | 2.0% |
|---|---|---|---|---|---|
| 6.6% | $27.9 | $27.9 | $29.0 | $30.3 | $31.9 |
| 7.6% | $25.4 | $25.4 | $26.2 | $27.1 | $28.2 |
| 8.6% | $23.6 | $23.6 | $24.1 | $24.8 | $25.5 |
| 9.6% | $22.1 | $22.1 | $22.5 | $23.0 | $23.5 |
| 10.6% | $20.9 | $20.9 | $21.2 | $21.6 | $22.0 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
